Literature DB >> 15530419

Selective inhibition of enterovirus 71 replication by short hairpin RNAs.

Wen-Wen Lu1, Yueh-Ying Hsu, Jyh-Yuan Yang, Szu-Hao Kung.   

Abstract

RNA interference (RNAi) is a sequence-specific, post-transcriptional process of mRNA degradation induced by small interfering RNA molecules. In this report, RNAi strategy was exploited to treat the infection of enterovirus 71 (EV71), considered as one of the most virulent pathogens that can cause severe complications in the family of Picornaviridae. We developed short hairpin RNA (shRNA) expression plasmids that significantly inhibited viral protein expression in a sequence-specific and dose-dependent fashion after transient transfection in cell cultures. Stable expression of shRNAs in cultured cells exhibited marked viral resistance in every step assessed in the viral replication. Using cytotoxicity of shRNA-expressing cells as a surrogate marker, it was shown that replication of EV71 was specifically attenuated by these plasmid-derived shRNAs, while replications of other related enteroviruses examined were not. These proof-of-concept studies demonstrated the feasibility of this approach for the therapy of EV71-associated diseases.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15530419     DOI: 10.1016/j.bbrc.2004.10.062

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  13 in total

1.  Silencing of hepatitis A virus infection by small interfering RNAs.

Authors:  Yuri Kusov; Tatsuo Kanda; Ann Palmenberg; Jean-Yves Sgro; Verena Gauss-Müller
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

Review 2.  Therapeutic and prevention strategies against human enterovirus 71 infection.

Authors:  Chee Choy Kok
Journal:  World J Virol       Date:  2015-05-12

3.  SLURP-1 and -2 in normal, immortalized and malignant oral keratinocytes.

Authors:  Juan Arredondo; Alexander I Chernyavsky; Sergei A Grando
Journal:  Life Sci       Date:  2007-01-13       Impact factor: 5.037

Review 4.  Slicing and dicing viruses: antiviral RNA interference in mammals.

Authors:  Pierre V Maillard; Annemarthe G van der Veen; Enzo Z Poirier; Caetano Reis e Sousa
Journal:  EMBO J       Date:  2019-03-14       Impact factor: 11.598

Review 5.  Antivirals and vaccines for Enterovirus A71.

Authors:  Jing-Yi Lin; Yu-An Kung; Shin-Ru Shih
Journal:  J Biomed Sci       Date:  2019-09-03       Impact factor: 8.410

Review 6.  Developments towards antiviral therapies against enterovirus 71.

Authors:  Kan X Wu; Mary M-L Ng; Justin J H Chu
Journal:  Drug Discov Today       Date:  2010-10-23       Impact factor: 7.851

7.  The highly conserved 5' untranslated region as an effective target towards the inhibition of Enterovirus 71 replication by unmodified and appropriate 2'-modified siRNAs.

Authors:  Jun-Xia Deng; Xiao-Jing Nie; Ying-Feng Lei; Chao-Feng Ma; Dong-Liang Xu; Biao Li; Zhi-Kai Xu; Guo-Cheng Zhang
Journal:  J Biomed Sci       Date:  2012-08-13       Impact factor: 8.410

Review 8.  Strategies to develop antivirals against enterovirus 71.

Authors:  Rei-Lin Kuo; Shin-Ru Shih
Journal:  Virol J       Date:  2013-01-22       Impact factor: 4.099

Review 9.  Recent developments in antiviral agents against enterovirus 71 infection.

Authors:  Chee Wah Tan; Jeffrey Kam Fatt Lai; I-Ching Sam; Yoke Fun Chan
Journal:  J Biomed Sci       Date:  2014-02-12       Impact factor: 8.410

10.  siRNA Targeting the 2Apro Genomic Region Prevents Enterovirus 71 Replication In Vitro.

Authors:  Haibing Liu; Yanyan Qin; Zhenzhen Kong; Qixiang Shao; Zhaoliang Su; Shengjun Wang; Jianguo Chen
Journal:  PLoS One       Date:  2016-02-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.